Order Article Reprints

Chira S, Nutu A, Isacescu E, Bica C, Pop L, Ciocan C, Berindan-Neagoe I. Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research. Cells. 2022; 11(18):2781. https://doi.org/10.3390/cells11182781

Chira, Sergiu, Andreea Nutu, Ecaterina Isacescu, Cecilia Bica, Laura Pop, Cristina Ciocan, and Ioana Berindan-Neagoe. 2022. "Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research" Cells 11, no. 18: 2781. https://doi.org/10.3390/cells11182781

Chira, S., Nutu, A., Isacescu, E., Bica, C., Pop, L., Ciocan, C., & Berindan-Neagoe, I. (2022). Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research. Cells, 11(18), 2781. https://doi.org/10.3390/cells11182781